Variant report
Variant | nsv964540 |
---|---|
Chromosome Location | chr21:28463562-28467460 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ADAMTS5-3 | chr21:28464268-28464333 | ucscGeneNc_uc002yml_2 |
2 | lnc-ADAMTS5-3 | chr21:28464268-28464333 | NONHSAT081561 |
3 | lnc-ADAMTS5-3 | chr21:28464268-28464333 | NONHSAT081559 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1888430 | chr21:28463564-28463565 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs565735961 | chr21:28463575-28463576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs17660254 | chr21:28463637-28463638 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs557849209 | chr21:28463782-28463783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs201826766 | chr21:28463825-28463826 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs150760853 | chr21:28463838-28463839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs375275704 | chr21:28463857-28463858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs537129463 | chr21:28463866-28463867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs187949220 | chr21:28463871-28463872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs564105407 | chr21:28463875-28463876 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs73363628 | chr21:28463935-28463936 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs543316282 | chr21:28463992-28463993 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs553656303 | chr21:28464007-28464008 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs2830679 | chr21:28464041-28464042 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs2040243 | chr21:28464068-28464069 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs138088409 | chr21:28464072-28464073 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs575343408 | chr21:28464091-28464092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs542669543 | chr21:28464151-28464152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs543962053 | chr21:28464175-28464176 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs561143926 | chr21:28464176-28464177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs529801839 | chr21:28464219-28464220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs538643574 | chr21:28464271-28464272 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs546508903 | chr21:28464284-28464285 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs191846110 | chr21:28464292-28464293 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs149548510 | chr21:28464294-28464295 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs551391412 | chr21:28464328-28464329 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs571306585 | chr21:28464334-28464335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs537593766 | chr21:28464362-28464363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs550758655 | chr21:28464365-28464366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs567850901 | chr21:28464373-28464374 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs536418036 | chr21:28464389-28464390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs116797623 | chr21:28464401-28464402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs573607192 | chr21:28464410-28464411 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs567915597 | chr21:28464411-28464412 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs571116896 | chr21:28464425-28464426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs117028221 | chr21:28464453-28464454 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs558626024 | chr21:28464515-28464516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs17660338 | chr21:28464539-28464540 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
39 | rs376047332 | chr21:28464598-28464599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs553679860 | chr21:28464637-28464638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs560790389 | chr21:28464729-28464730 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs547503486 | chr21:28464732-28464733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs144132242 | chr21:28464735-28464736 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs200157265 | chr21:28464819-28464820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs71183598 | chr21:28464823-28464824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs77370403 | chr21:28464855-28464856 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs559896567 | chr21:28464879-28464880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs368603696 | chr21:28464919-28464920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs552045736 | chr21:28464978-28464979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs188877744 | chr21:28465004-28465005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Down syndrome | 17412756 | CNVD |
Down syndrome | 17576883 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Seminomas | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Prostate cancer | 19156837 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Alzheimer''s disease | 18923514 | CNVD |
Alzheimer''s disease | 20877625 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Alzheimer''s disease | 21956041 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Melanoma | 18172304 | CNVD |
Autism | 22958593 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr21:28447400-28467200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
2 | chr21:28458800-28477600 | Weak transcription | Fetal Kidney | kidney |
3 | chr21:28462400-28466800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr21:28463000-28466600 | Weak transcription | Adipose Nuclei | Adipose |
5 | chr21:28466400-28466800 | Enhancers | Ovary | ovary |
6 | chr21:28466600-28466800 | Enhancers | Adipose Nuclei | Adipose |
7 | chr21:28466800-28467200 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr21:28466800-28467200 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
9 | chr21:28466800-28467200 | Flanking Active TSS | Adipose Nuclei | Adipose |
10 | chr21:28467000-28467600 | Active TSS | Ovary | ovary |
11 | chr21:28467200-28467400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
12 | chr21:28467200-28467400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
13 | chr21:28467200-28467400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
14 | chr21:28467200-28467400 | Enhancers | Adipose Nuclei | Adipose |